Surgery Partners Inc(SGRY) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:30 PM ET (Korea 9/12 08:30)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.69 | Insider Own | 40.42% | Shs Outstand | 130.9M | Perf Week | 1.48% |
| Market Cap | 1.88B | Forward P/E | 26.51 | EPS next Y | 20.46% | Insider Trans | -0.06% | Shs Float | 78.0M | Perf Month | -6.14% |
| Enterprise Value | 7.52B | PEG | 1.92 | EPS next Q | 0.11 | Inst Own | 82.69% | Short Float | 16.61% | Perf Quarter | -3.75% |
| Income | -0.09B | P/S | 0.56 | EPS this Y | -4.2% | Inst Trans | -0.46% | Short Ratio | 6.8 | Perf Half Y | 12.87% |
| Sales | 3.37B | P/B | 1.13 | EPS next 5Y | 13.84% | ROA | -1.11% | Short Interest | 12.95M | Perf YTD | -6.93% |
| Book/sh | 12.76 | P/C | 8.69 | EPS past 3/5Y | -1.03% 28.11% | ROE | -5.18% | 52W High | -38.65% ($23.44) | Perf Year | -34.96% |
| Cash/sh | 1.66 | P/FCF | 10.04 | Sales past 3/5Y | 9.22% 12.21% | ROIC | -1.59% | 52W Low | 26.03% ($11.41) | Perf 3Y | -56.11% |
| Dividend Est. | - | EV/EBITDA | 11.82 | EPS Y/Y TTM | 51.58% | Gross Margin | 17.25% | Volatility(W/M) | 4.08% 4.86% | Perf 5Y | -70.12% |
| Dividend TTM | - | EV/Sales | 2.23 | Sales Y/Y TTM | 3.99% | Oper. Margin | 13.64% | ATR (14) | 0.7 | Perf 10Y | -25.07% |
| Dividend Ex-Date | - | Quick Ratio | 1.78 | EPS Q/Q | -490.86% | Profit Margin | -2.63% | RSI (14) | 49.09 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.95 | Sales Q/Q | 2.75% | SMA20 | 1.69% ($14.14) | Beta | 1.9 | Target Price | $18.73 |
| Payout | - | Debt/Eq | 2.43 | Earnings | 2026/8/10 | SMA50 | -5.31% ($15.19) | Rel Volume | 0.68 | Prev Close | $14.12 |
| Employees | 16000 | LT Debt/Eq | 2.34 | EPS/Sales Surpr. | 72.71% 2.27% | SMA200 | -2.34% ($14.72) | Avg Volume(3M) | 1.91M | Price | $14.38 |
| IPO | 2015/10/1 | Option/Short | Yes/Yes | Trades | 11607 | Volume | 1,287,704 | Change | 1.84% |
Company
SGRY is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🏥 A U.S. healthcare company that operates outpatient surgery centers and surgical facilities. In collaboration with physicians, it runs outpatient surgery centers and short-stay surgical hospitals, providing ambulatory surgical services that can be performed without hospital admission. The company has established itself as a surgical facility operator that combines a cost-efficient outpatient surgery model with physician partnerships.
Over the past 1 year, on the lower side
39% below its 1-year high.
SGRY has weak earning power
13.64% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -4.2% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -56.1% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 82.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
XHS 0.02%
XCCC 0.01%
XHYH 0.01%
IBHL 0.01%
HYLS 0.01%It ranks #4 in the industry
Based on market cap of $2B.
SGRY $2B PER -
HCA $92B PER 14.3
THC $21B PER 10.2
EHC $12B PER 19.8
FAQ
What kind of company is SGRY?
SGRY belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of SGRY?
The market cap of SGRY is approximately $1.9B, ranking 2,154 within its sector.
What is the 52-week high and low for SGRY?
SGRY has recorded a 52-week high of $23.44 and a low of $11.41.
